G'day Hadrian,
you must have a memory like an elephant to dig out that 4 year old preso.
But it tells me Cosette must know MYX pretty well. I presume they are dermatology products as I read somewhere that's a Cosette specialty.
Seem's like we both believe the offer is a dud, me the cash and you the big sales and gross margin turnaround story.
I wonder what the numbers for sales would be over the next few years as sales growth seems to be accelerating.
Like a mad Collingwood fan I too want to stick around for another premiership cup or in the case of MYX a big share price increase. Something very strange would have to happen for me to accept this deal, so I suppose the computer says no and that's how i will vote.
The thing that gets me is that from what I have read is that MYX has successfully by-passed the pharmacy benefit manager and is now starting to show higher gross margins and therefore more cash profit made. I hope others can recognise this significant improvement is already there and current shareholders should be rewarded for it and not just give it away for $7.40
Many thanks for your input, no need to respond.
Cheers......D
Go Pies!!! (battle of the stripes on Saturday night)
- Forums
- ASX - By Stock
- Not in my best interest - Mr Chairman
MYX
mayne pharma group limited
Add to My Watchlist
2.30%
!
$5.34

G'day Hadrian, you must have a memory like an elephant to dig...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.34 |
Change
0.120(2.30%) |
Mkt cap ! $433.8M |
Open | High | Low | Value | Volume |
$5.29 | $5.34 | $5.15 | $705.4K | 133.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | $5.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.34 | 3653 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 5.310 |
1 | 864 | 5.290 |
1 | 28009 | 5.280 |
2 | 2631 | 5.250 |
1 | 402 | 5.240 |
Price($) | Vol. | No. |
---|---|---|
5.340 | 3653 | 3 |
5.350 | 16680 | 3 |
5.370 | 1631 | 1 |
5.390 | 1631 | 1 |
5.400 | 26805 | 3 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online